Developing and validating polygenic risk scores for colorectal cancer risk prediction in East Asians

Several polygenic risk scores (PRSs) have been developed to predict the risk of colorectal cancer (CRC) in European descendants. We used genome‐wide association study (GWAS) data from 22 702 cases and 212 486 controls of Asian ancestry to develop PRSs and validated them in two case‐control studies (...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of cancer Vol. 151; no. 10; pp. 1726 - 1736
Main Authors Ping, Jie, Yang, Yaohua, Wen, Wanqing, Kweon, Sun‐Seog, Matsuda, Koichi, Jia, Wei‐Hua, Shin, Aesun, Gao, Yu‐Tang, Matsuo, Keitaro, Kim, Jeongseon, Kim, Dong‐Hyun, Jee, Sun Ha, Cai, Qiuyin, Chen, Zhishan, Tao, Ran, Shin, Min‐Ho, Tanikawa, Chizu, Pan, Zhi‐Zhong, Oh, Jae Hwan, Oze, Isao, Ahn, Yoon‐Ok, Jung, Keum Ji, Ren, Zefang, Shu, Xiao‐Ou, Long, Jirong, Zheng, Wei
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 15.11.2022
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN0020-7136
1097-0215
1097-0215
DOI10.1002/ijc.34194

Cover

More Information
Summary:Several polygenic risk scores (PRSs) have been developed to predict the risk of colorectal cancer (CRC) in European descendants. We used genome‐wide association study (GWAS) data from 22 702 cases and 212 486 controls of Asian ancestry to develop PRSs and validated them in two case‐control studies (1454 Korean and 1736 Chinese). Eleven PRSs were derived using three approaches: GWAS‐identified CRC risk SNPs, CRC risk variants identified through fine‐mapping of known risk loci and genome‐wide risk prediction algorithms. Logistic regression was used to estimate odds ratios (ORs) and area under the curve (AUC). PRS115‐EAS, a PRS with 115 GWAS‐reported risk variants derived from East‐Asian data, validated significantly better than PRS115‐EUR derived from European descendants. In the Korea validation set, OR per SD increase of PRS115‐EAS was 1.63 (95% CI = 1.46‐1.82; AUC = 0.63), compared with OR of 1.44 (95% CI = 1.29‐1.60, AUC = 0.60) for PRS115‐EUR. PRS115‐EAS/EUR derived using meta‐analysis results of both populations slightly improved the AUC to 0.64. Similar but weaker associations were found in the China validation set. Individuals among the highest 5% of PRS115‐EAS/EUR have a 2.52‐fold elevated CRC risk compared with the medium (41‐60th) risk group and have a 12% to 20% risk of developing CRC by age 85. PRSs constructed using results from fine‐mapping and genome‐wide algorithms did not perform as well as PRS115‐EAS and PRS115‐EAS/EUR in risk prediction, possibly due to a small sample size. Our results indicate that CRC PRSs are promising in predicting CRC risk in East Asians and highlights the importance of using population‐specific data to build CRC risk prediction models. What's new? Several polygenic risk scores (PRS) have been developed to predict colorectal cancer risk in European‐ancestry populations. Using data from large genome‐wide association studies, here the authors developed and validated PRSs for colorectal cancer risk prediction in East Asians. The PRS derived from this study showed a similar discriminatory ability in classifying cases and controls as that previously reported in European‐ancestry populations. The findings support the utility of PRSs in identifying high‐risk individuals for colorectal cancer prevention in Asians and highlight the importance of using population‐specific data to build colorectal cancer risk prediction models.
Bibliography:Funding information
National Institutes of Health, Grant/Award Numbers: R01CA124558, R01CA148667, R01CA158473, R01CA188214, R37CA070867, UM1CA182910, R01CA082729, UM1CA173640, R01CA064277, R01CA092585, P30CA068485; Seoul R&D Program, Grant/Award Number: 10526; National R&D Program for Cancer Control, Republic of Korea, Grant/Award Number: 1631020; National Cancer Center Korea, Grant/Award Number: 0910220; Korea‐NCC (National Cancer Center) Colorectal Cancer Study (Basic Science Research Program through the National Research Foundation of Korea, Grant/Award Numbers: 2013R1A1A2A10008260, 2010‐0010276; Aichi Colorectal Cancer Study (Grant‐in‐Aid for Cancer Research, grant for the Third Term Comprehensive Control Research for Cancer and Grants‐in‐Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology), Grant/Award Numbers: 221S0001, 17015018; Japan BioBank Colorectal Cancer Study (grant from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government); Hwasun Cancer Epidemiology Study‐Colon and Rectum Cancer (HCES‐CRC; grants from Chonnam National University Hwasun Hospital Biomedical Research Institute), Grant/Award Number: HCRI18007; Natural Science Foundation of China, Grant/Award Number: 81072383; National Basic Research Program, Grant/Award Number: 2011CB504303; National Key Scientific and Technological Project, Grant/Award Number: 2011ZX09307‐001‐04; Anne Potter Wilson Chair funds from Vanderbilt University School of Medicine
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0020-7136
1097-0215
1097-0215
DOI:10.1002/ijc.34194